Cargando…

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights

MiTF/TFE translocation renal cell carcinoma (tRCC) is a rare and aggressive subtype of RCC representing the most prevalent RCC in the pediatric population (up to 40%) and making up 4% of all RCCs in adults. It is characterized by translocations involving either TFE3 (TFE3-tRCC), TFEB (TFEB-tRCC) or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simonaggio, Audrey, Ambrosetti, Damien, Verkarre, Virginie, Auvray, Marie, Oudard, Stéphane, Vano, Yann-Alexandre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324307/ https://www.ncbi.nlm.nih.gov/pubmed/35886994 http://dx.doi.org/10.3390/ijms23147649

Ejemplares similares

The Regulation of MiTF/TFE Transcription Factors Across Model Organisms: from Brain Physiology to Implication for Neurodegeneration
por: Agostini, Francesco, et al.
Publicado: (2022)

Enhance the Immune Checkpoint Inhibitors Efficacy with Radiotherapy Induced Immunogenic Cell Death: A Comprehensive Review and Latest Developments
por: Procureur, Adrien, et al.
Publicado: (2021)

Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC)
por: Simonaggio, Audrey, et al.
Publicado: (2021)

Resistance to cancer immunotherapy in metastatic renal cell carcinoma
por: Moreira, Marco, et al.
Publicado: (2020)

Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies
por: Guillaume, Zoé, et al.
Publicado: (2022)

The underestimated role of the microphthalmia-associated transcription factor (MiTF) in normal and pathological haematopoiesis
por: Oppezzo, Alessia, et al.
Publicado: (2021)

FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells
por: Bourseguin, Julie, et al.
Publicado: (2016)

Mechanism of conditional partner selectivity in MITF/TFE family transcription factors with a conserved coiled coil stammer motif
por: Pogenberg, Vivian, et al.
Publicado: (2020)

MiTF is Associated with Chemoresistance to Cisplatin in A549 Lung Cancer Cells via Modulating Lysosomal Biogenesis and Autophagy
por: Li, Wei, et al.
Publicado: (2020)

Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib
por: Guillaume, Zoé, et al.
Publicado: (2020)

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma
por: Pei, Jianming, et al.
Publicado: (2019)

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders
por: Boilève, A., et al.
Publicado: (2018)

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma
por: Sun, Guangxi, et al.
Publicado: (2021)

A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion
por: Ye, Hong, et al.
Publicado: (2019)

Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit
por: Joseph, Adrien, et al.
Publicado: (2020)

Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements
por: Lee, Seok Joo, et al.
Publicado: (2016)

Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges
por: Fournier, Laure, et al.
Publicado: (2017)

Nuclear translocation of TFE3 under hypoxia enhances the engraftment of human hematopoietic stem cells
por: Wang, Xuepeng, et al.
Publicado: (2022)

Renal malacoplakia: Case report of a differential diagnosis for renal cell carcinoma
por: Ayllon, Jorge, et al.
Publicado: (2012)

Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients
por: Vano, Yann-Alexandre, et al.
Publicado: (2018)

MiT/TFE Family Renal Cell Carcinoma
por: Tang, Jinglong, et al.
Publicado: (2023)

Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis
por: Elaidi, Reza, et al.
Publicado: (2020)

Emerging roles and regulation of MiT/TFE transcriptional factors
por: Yang, Min, et al.
Publicado: (2018)

MiT/TFE Family of Transcription Factors: An Evolutionary Perspective
por: La Spina, Martina, et al.
Publicado: (2021)

MiTF links Erk1/2 kinase and p21(CIP1/WAF1 )activation after UVC radiation in normal human melanocytes and melanoma cells
por: Liu, Feng, et al.
Publicado: (2010)

Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
por: Ling, Wenwu, et al.
Publicado: (2017)

Dissection of tumor-intrinsic and tumor-extrinsic features of MiT/TFE translocation renal cell carcinoma via single-cell RNA sequencing
por: Konda, Prathyusha, et al.
Publicado: (2023)

Postoperative recurrence of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
por: Wang, Zhen, et al.
Publicado: (2017)

Primary Xp11 translocation PEComa of the testis with SFPQ⁃TFE3 rearrangement: a case report and review of the literature
por: Zhang, Huizhi, et al.
Publicado: (2023)

Multiparameter phenotypic screening for endogenous TFEB and TFE3 translocation identifies novel chemical series modulating lysosome function
por: Carling, Phillippa J, et al.
Publicado: (2022)

Plasticity of melanoma and EMT-TF reprogramming
por: Tulchinsky, Eugene, et al.
Publicado: (2013)

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
por: Liu, Ning, et al.
Publicado: (2016)

Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents
por: Cao, Chuanzhen, et al.
Publicado: (2022)

Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
por: Zhou, Jiale, et al.
Publicado: (2022)

Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates
por: Alaghehbandan, Reza, et al.
Publicado: (2022)

Radiation hardness of lead glasses TF1 and TF101
por: Kobayashi, M, et al.
Publicado: (1993)

miR-148 Regulates Mitf in Melanoma Cells
por: Haflidadóttir, Benedikta S., et al.
Publicado: (2010)

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas
por: Lu, Xiaofan, et al.
Publicado: (2023)

Emerging roles of TFE3 in metabolic regulation
por: Li, Xingyu, et al.
Publicado: (2023)

MITF links maturation and quiescence
por: LeBrasseur, Nicole
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_t67v6t52ts37rrhc18omjv8ocq